Qualitative Expression Analysis of Interferon Alpha Receptor in HCV Patients Resistant to Interferon Therapy

dc.contributor.author	Bashir Qudsia
dc.date.accessioned	2021-08-23T06:20:48Z
dc.date.available	2021-08-23T06:20:48Z
dc.date.issued	2015
dc.identifier.uri	http://10.250.8.41:8080/xmlui/handle/123456789/25445
dc.description.abstract	Hepatitis C virus (HCV) is a leading cause of hepatocellular carcinoma (HCC) and cirrhosis. More than 3% of the world population and about 6% of Pakistanis are currently living with the virus (genotype 3 most prevalent). Interferon alpha (IFN-α) plus ribavirin is widely used standard therapy for chronic HCV treatment all over the world but pegylated interferon along with ribavirin has higher response rate than that of standard interferon. Objective	en_US
dc.language.iso	en	en_US
dc.publisher	Atta Ur Rahman School of Applied Biosciences (ASAB), NUST	en_US
dc.subject	Qualitative, Interferon, Receptorin, HCV, Patients, Therapy	en_US
dc.title	Qualitative Expression Analysis of Interferon Alpha Receptor in HCV Patients Resistant to Interferon Therapy	en_US
dc.type	Thesis	en_US